No evidence for predictors of response to atomoxetine treatment of attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder.
1 Department of Psychiatry, University of Groningen , University Medical Center Groningen, Groningen, The Netherlands .
Myriam
M
Harfterkamp
Dennis
D
van der Meer
Gigi
G
van der Loo-Neus
Jan K
JK
Buitelaar
Ruud B
RB
Minderaa
Pieter J
PJ
Hoekstra
D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000069445:Atomoxetine Hydrochloride / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000067877:Autism Spectrum Disorder / Q000150:complications*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male
D018759:Adrenergic Uptake Inhibitors; D000069445:Atomoxetine Hydrochloride